Currently, in influenza vaccine production via the chicken embryo splitting method, embryo viability detection is a pivotal quality control step—non-viable embryos are prone to microbial contamination, directly endangering the vaccine batch quality. However, the predominant manual candling method suffers from unstable accuracy and occupational visual health risks. To address this challenge, we developed a novel real-time embryo viability detection system based on photoplethysmography (PPG) technology, comprising a hardware circuit for chicken embryo PPG signal collection and customized software for real-time signal filtering and time–frequency-domain analysis. Based on this system, we conducted three pivotal experiments: (1) impact of the source–detector spatial arrangement on PPG signal acquisition, (2) viable/non-viable embryo discrimination, and (3) embryo PPG signal detection performance for days 10–14. The experimental results show that within the sample size (15 viable, 5 non-viable embryos), the system achieved a 100% discrimination accuracy; meanwhile, it realized 100% successful multi-day (days 10–14) PPG signal capture for the 15 viable embryos, with consistent performance across the developmental stages. This PPG-based system overcomes limitations of traditional and existing automated methods, provides a non-invasive alternative for embryo viability detection, and presents significant implications for standardizing vaccine production quality control and advancing optical biosensing for biological viability detection.
Liu et al. (Sat,) studied this question.